Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies
Go back to Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies| AGENUS (NASDAQ: AGEN) | Delayed: 7.99 +0.38 (4.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.61 | 52 Week High | $7.49 | |||
| Open | $7.56 | 52 Week Low | $2.61 | |||
| Day High | $8.00 | P/E | N/A | |||
| Day Low | $7.54 | EPS | $-1.10 | |||
| Volume | 676,466 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 149.92 +3.58 (2.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.34 | 52 Week High | $108.63 | |||
| Open | $148.52 | 52 Week Low | $71.39 | |||
| Day High | $149.96 | P/E | 82.83 | |||
| Day Low | $146.92 | EPS | $1.81 | |||
| Volume | 4,870,704 | |||||
